TABLE-Cyfuse Biomedical - Q1 parent results

About this update from Cyfuse Biomedical K.k.

May 15 (Reuters)- Cyfuse Biomedical K.K. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 3 months ended 3 months ended Year to Mar 31, 2026 Mar 31, 2025 Dec 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 28 mln 24 mln 278 mln (+17.6 pct) (+125.3 pct) (+20.4 pct) Operating loss 215 mln loss 240 mln loss 1.08 Recurring loss 223 mln loss 162 mln loss 1.06 Net loss 224 mln loss 162 mln loss 1.06 EPS loss 22.56 yen loss 19.90 yen loss 110.22 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Cyfuse Biomedical K.K.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T

View stock analysis, news, and events for Cyfuse Biomedical K.k.